Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine mouthwash for chemotherapy-induced oral mucositis in children
IRCT20201218049750N1Phase 3Completed
- Sponsor
- Congenital pediatric Hematologic diseases
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ketamine in stomatitis (2 arms), sponsored by Congenital pediatric Hematologic diseases. Primary endpoints: Mucositis grading, Pain severity and 3 more. Started May 2019; status: completed.
02
Drugs
ketamine
03
Conditions
stomatitis
Beyond the preview
Go deeper on IRCT20201218049750N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201218049750N1.